Rectal aminosalicylate therapy for distal ulcerative colitis: a meta‐analysis
Authors:
- 1 June 1995
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 9 (3) , 293-300
Abstract
SUMMARY: Background: To summarize and quantify the evidence supporting rectal 5‐ or 4‐aminosalicylate (ASA) therapies for disease exacerbation or remission maintenance in distal ulcerative colitis, we performed a meta‐analysis. Methods: All randomized, double‐blind controlled trials involving aminosalicylate therapy were retrieved from a MEDLINE search, review articles on ulcerative colitis therapy or their bibliographies. Of 55 studies retrieved, 19 met the inclusion criteria. Appraisal and data extraction were performed by two observers and scoring disagreements were resolved by consensus. Results: Eleven trials tested 5‐ASA and three tested 4‐ASA in active ulcerative colitis. 5‐ASA was superior to placebo for inducing remission or symptomatic improvement in active ulcerative colitis with a pooled odds ratio of 7.36 (95% Confidence interval (CI): 4.72–11.47). In four trials the pooled odds ratio for endoscopic improvement was 10.04 (95 % CI: 5.72–17.61) and for histological improvement 10.31 (95% CI: 5.85–18.18). Studies evaluating 4–ASA suggest a benefit similar to prednisolone in treating active disease. Five trials assessed remission maintenance with 5‐ASA, and when compared to placebo gave a pooled odds ratio of 16.22 (95% CI: 4.71–55.92). No dose‐response relationship was observed. ASA compounds were not therapeutically superior to other treatments. Conclusions: We conclude that rectal 5‐ASA is effective therapy for active distal ulcerative colitis. More trials are needed to assess 4‐ASA, dose‐response effects and the ideal regimen for remission maintenance.Keywords
This publication has 42 references indexed in Scilit:
- Medical therapy of ulcerative colitisThe Lancet, 1993
- Clinical patterns, natural history, and progression of ulcerative colitisDigestive Diseases and Sciences, 1993
- A prospective randomized double blind trial comparing prednisolone and 4-aminosalicylic acid enemas in acute distal ulcerative colitisJournal of Gastroenterology and Hepatology, 1992
- Retrograde Spread of Mesalazine (5-Aminosalicylic Acid)-Containing Enema in Patients with Ulcerative ColitisClinical Pharmacokinetics, 1991
- Comparison of 5-Aminosalicylic Acid (3 g) and Prednisolone Phosphate Sodium Enemas (30 mg) in the Treatment of Distal Ulcerative Colitis: A Prospective, Randomized, Double-Blind TrialScandinavian Journal of Gastroenterology, 1988
- Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using99mTc-labeled 5-ASA suppositoriesDigestive Diseases and Sciences, 1987
- Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditisDigestive Diseases and Sciences, 1987
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Retrograde spreading of hydrocortisone enema in inflammatory bowel diseaseDigestive Diseases and Sciences, 1986
- Retrograde Colonic Spread of Sulphasalazine EnemasScandinavian Journal of Gastroenterology, 1982